Response: Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3

Debra L. Barton; Jeff A. Sloan; Charles L. Loprinzi; Rui Qin

doi:10.1093/jnci/djn312

Response: Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3

Debra L. Barton, Jeff A. Sloan, Charles L. Loprinzi, Rui Qin

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1482
Number of pages	1
Journal	Journal of the National Cancer Institute
Volume	100
Issue number	20
DOIs	https://doi.org/10.1093/jnci/djn312
State	Published - Oct 2008

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/djn312

Cite this

Response: Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3. / Barton, Debra L.; Sloan, Jeff A.; Loprinzi, Charles L. et al.
In: Journal of the National Cancer Institute, Vol. 100, No. 20, 10.2008, p. 1482.

Research output: Contribution to journal › Letter › peer-review

@article{9f824496030d41e8a7a1c0b62620ddff,

title = "Response: Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3",

author = "Barton, {Debra L.} and Sloan, {Jeff A.} and Loprinzi, {Charles L.} and Rui Qin",

year = "2008",

month = oct,

doi = "10.1093/jnci/djn312",

language = "English (US)",

volume = "100",

pages = "1482",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "20",

}

TY - JOUR

T1 - Response

T2 - Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3

AU - Barton, Debra L.

AU - Sloan, Jeff A.

AU - Loprinzi, Charles L.

AU - Qin, Rui

PY - 2008/10

Y1 - 2008/10

UR - http://www.scopus.com/inward/record.url?scp=54149119003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54149119003&partnerID=8YFLogxK

U2 - 10.1093/jnci/djn312

DO - 10.1093/jnci/djn312

M3 - Letter

AN - SCOPUS:54149119003

SN - 0027-8874

VL - 100

SP - 1482

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 20

ER -

Response: Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this